The possible involvement of mutagenic and carcinogenic heterocyclic amines in human cancer

Acrylamide and Other Hazardous Compounds in Heat-Treated Foods

Volumn , Issue , 2006, Pages 296-327

  Totsuka, Yukari ^a   Nishigaki, Rena ^a   Sugimura, Takashi ^a   Wakabayashi, Keiji ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 50049112195     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-84569-011-3.50014-8     Document Type: Chapter

References (172)

1. Arimoto S., Ohara Y., Namba T., Negishi T., Hayatsu H. Inhibition of the mutagenicity of amino acid pyrolysis products by hemin and other biological pyrole pigments. Biochem. Biophys. Res. Commun 1980, 92:662-668.
2. Barrett J.H., Smith G., Waxman R., Gooderham N., Lightfoot T., Garner R.C., Augustsson K., Wolf C.R., Bishop D.T., Forman D. Investigation of interaction between N-acetyltransferase 2 and heterocyclic amines as potential risk factors for colorectal cancer. Carcinogenesis 2003, 24:275-282.
3. Bayoumy K.E., Donahue J.M., Hecht S.S., Hoffmann D. Identification and quantitative determination of aniline and toluidines in human urine. Cancer Res 1986, 46:6064-6067.
4. Becher G., Knize M.G., Nes I.F., Felton J.S. Isolation and identification of mutagens from a fried Norwegian meat product. Carcinogenesis 1988, 9:247-253.
5. Bell D.A., Stephens E.A., Castranio T., Umbach D.M., Watson M., Deakin M., Elder J., Hendrickse C., Duncan H., Strange R.C. Polyadenylation polymorphism in the acetyltransferase 1 gene (NAT1) increases risk of colorectal cancer. Cancer Res 1995, 55:3537-3542.
6. Brittebo E.B., Skog K.I., Jägerstad I.M. Binding of the food mutagen PhIP in pigmented tissues of mice. Carcinogenesis 1992, 13:2263-2269.
7. Brockton N., Little J., Sharp L., Cotton S.C. N-acetyltransferase polymorphisms and colorectal cancer: a HuGE review. Am. J. Epidemiol 2000, 151:846-861.
8. Cantwell M., Mittl B., Curtin J., Carroll R.J., Potischman N., Caporaso N.E., Sinha R. Relative validity of a food frequency questionnaire with a meat-cooking and heterocyclic amine module. Cancer Epidemiol. Biomarkers Prev 2004, 13:293-298.
9. Chevalier D., Cauffiez C., Allorge D., Lo-Guidice J.M., Lhermitte M., Lafitte J.J., Broly F. Five novel natural allelic variants-951A>C, 1042G>A (D348N), 1156A>T (I386F), 1217G>A (C406Y) and 1291C>T (C431Y)-of the human CYP1A2 gene in a French Caucasian population. Hum Mutat 2001, 17:355-356.
10. Dashwood R.H. Use of transgenic and mutant animal models in the study of heterocyclic amine-induced mutagenesis and carcinogenesis. J. Biochem. Mol. Biol 2003, 36:35-42.
11. Dashwood R.H., Suzui M., Nakagama H., Sugimura T., Nagao M. High frequency of b-catenin (Ctnnb1) mutations in the colon tumors induced by two heterocyclic amines in the F344 rat. Cancer Res 1998, 58:1127-1129.
12. DeBruin L.S., Pawliszyn J.B., Josephy P.D. Detection of monocyclic aromatic amines, possible mammary carcinogenesis, in human milk. Chem. Res. Toxicol 1999, 12:78-82.
13. DeBruin L.S., Martos P.A., Josephy P.D. Detection of PhIP (2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine) in the milk of healthy women. Chem. Res. Toxicol 2001, 14:1523-1528.
14. Delfino R.J., Sinha R., Smith C., West J., White E., Lin H.J., Liao S.Y., Gim J.S., Ma H.L., Butler J., Anton-Culver H. Breast cancer, heterocyclic aromatic amines from meat and the N-acetyltransferase 2 genotype. Carcinogenesis 2000, 21:607-615.
15. De Stefani E., Boffetta P., Mendilaharsu M., Carzoglio J., Deneo-Pellegrini H. Dietary nitrosamines, heterocyclic amines, and risk of gastric cancer: a case-control study in Uruguay. Nutr. Cancer 1998, 30:158-162.
16. Dingley K.H., Curtis K.D., Nowell S., Felton J.S., Lang N.P., Turteltaub K.W. DNA and protein adduct formation in the colon and blood of humans after exposure to a dietary-relevant dose of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Cancer Epidemiol Biomarkers Prev 1999, 8:507-512.
17. Doll R., Peto R. The causes of cancer: Quantitative estimates of avoidable risks of cancer in the United States today. J. Natl. Cancer Inst 1981, 66:1191-1308.
18. Endo H., Schut H.A.J., Snyderwine E.G. Mutagenic specificity of 2-amino-3-methylimidazo[4,5-f]quinoline and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in the supF shuttle vector system. Cancer Res 1994, 54:3745-3751.
19. Esumi H., Ohgaki H., Kohzen E., Takayama S., Sugimura T. Induction of lymphoma in CDF1 mice by the food mutagen, 2-amino-methyl-6-phenyl-imidazo[4,5-b]pyridine. Jpn J Cancer Res 1989, 80:1176-1178.
20. Felton J.S., Knize M.G., Shen N.H., Lewis P.R., Andersen B.D., Happe J., Hatch F.T. The isolation and identification of a new mutagen from fried ground beef: 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). Carcinogenesis 1986, 7:1081-1086.
21. Felton J.S., Jägerstad M., Knize M.G., Skog K., Wakabayashi K. Contents in foods, beverages and tobacco. Food Borne Carcinogens: Heterocyclic Amines 2000, 31-71. John Wiley & Sons Ltd., Chichester. M. Nagao, T. Sugimura (Eds.).
22. Felton J.S., Knize M.G., Salmon C.P., Malfatti M.A., Kulp K.S. Human exposure to heterocyclic amine food mutagens/carcinogens: relevance to breast cancer. Environ. Mol. Mutagen 2002, 39:112-118.
23. Ferguson L.R., Harris P.J. Studies on the role of specific dietary fibers in protection against cololectal cancer. Mutat. Res 1996, 350:173-184.
24. 32P-postlabeling. Chem. Res. Toxicol 1994, 7:733-739.
25. Fukushima S., Wanibuchi H., Morimura K., Wei M., Nakae D., Konishi Y., Tsuda H., Uehara N., Imaida K., Shirai T., Tatematsu M., Tsukamoto T., Hirose M., Furukawa F., Wakabayashi K., Totsuka Y. Lack of a dose-response relationship for carcinogenicity in the rat liver with low doses of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline or N-nitrosodiethylamine. Jpn J Cancer Res 2002, 93:1076-1082.
26. Fukushima S., Wanibuchi H., Morimura K., Iwai S., Nakae D., Kishida H., Tsuda H., Uehara N., Imaida K., Shirai T., Tatematsu M., Tsukamoto T., Hirose M., Furukawa F. Existence of a threshold for induction of aberrant crypt foci in the rat colon with low doses of 2-amino-1-methyl-6-phenolimidazo[4,5-b]pyridine. Toxicol Sci 2004, 80:109-114.
27. Gerhardsson De Verdier M., Hagman U., Peters R.K., Steineck G., Overvik E. Meat, cooking methods and colorectal cancer: a case-referent study in Stockholm. Int. J. Cancer 1991, 49:520-525.
28. Ghoshal A., Preisegger K.H., Takayama S., Thorgeirsson S.S., Snyderwine E.G. Induction of mammary tumors in female Sprague-Dawley rats by the food-derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and effect of dietary fat. Carcinogenesis 1994, 15:2429-2433.
29. Glatt H. Sulfotransferases in the bioactivation of xenobiotics. Chemico-Biol. Interact 2000, 129:141-170.
30. Gorlewska-Roberts K., Green B., Fares M., Ambrosone C.B., Kadlubar F.F. Carcinogen-DNA adducts in human breast epithelial cells. Environ Mol Mutagen 2002, 39:184-192.
31. Guo D., Horio D.T., Grove J.S., Dashwood R.H. Inhibition by chlorophyllin of 2-amino-3-methylimidazo[4,5-f]quinoline-induced tumorigenesis in the male F344 rat. Cancer Lett 1995, 95:161-165.
32. Guo D., Schut H.A.J., Davis C.D., Snyderwine E.G., Bailey G.S., Dashwood R.H. Protection by chlorophyllin and indole-3-carbinol against 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced DNA adducts and colonic aberrant crypts in the F344 rat. Carcinogenesis 1995, 16:2931-2937.
33. Hada N., Totsuka Y., Enya T., Tsurumaki K., Nakazawa M., Kawahara N., Murakami Y., Yokoyama Y., Sugimura T., Wakabayashi K. Structures of mutagens produced by the co-mutagen norharman with o- and m-toluidine isomers. Mutat. Res 2001, 493:115-126.
34. Hammons G.J., Miton D., Stepps K., Guengerrich F.P., Tukey R.H., Kadlubar F.F. Metabolism of carcinogenic heterocyclic and aromatic amines by recombinant human cytochrome P450 enzymes. Carcinogenesis 1997, 18:851-854.
35. Hasegawa S., Imaida K., Shirai T., Nagao M., Sugimura T., Ito N. Dose-dependence of 2-amino-1-methyl-6-phenylimidazo[4,5-b]-pyridine (PhIP) carcinogenicity in rats. Carcinogenesis 1993, 14:2553-2557.
36. Hasegawa R., Hirose M., Kato T., Hagiwara A. Inhibitory effect of chlorophyllin on PhIP-induced mammary carcinogenesis in female F344 rats. Carcinogenesis 1995, 16:2243-2246.
37. Hashimoto H., Hanaoka T., Kobayashi M., Tsugane S. Analytical method of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in human hair by column-switching liquid chromatography-mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life. Sci 2004, 803:209-213.
38. Hein D.W. N-Acetyltransferase genetics and their role in predisposition to aromatic and heterocyclic amine-induced carcinogenesis. Toxicol. Lett 2000, 112-113:349-356.
39. Hein D.W. Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis. Mutat. Res 2002, 506-507:65-77.
40. Hein D.W., Doll M.A., Rustan T.D., Gray K., Feng Y., Ferguson R.J., Grant D.M. Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases. Carcinogenesis 1993, 14:1633-1638.
41. Hein D.W., Doll M.A., Fretland A.J., Leff M.A., Webb S.J., Xiao G.H., Devanaboyina U.S., Nangju N.A., Feng Y. Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. Cancer Epidemiol. Biomarkers Prev 2000, 9:29-42.
42. Herzog C.R., Schut H.A., Maronpot R.R., You M. Ras mutations in 2-amino-3-methylimidazo[4,5-f]quinoline-induced tumors in the CDF1 mouse. Mol. Carcinog 1993, 8:202-207.
43. Ikeda M., Yoshimoto K., Yoshimura T., Kono S., Kato H., Kuratsune M. A cohort study on the possible association between broiled fish intake and cancer. Gann 1983, 74:640-648.
44. International Agency For Research On Cancer (IARC) Aniline and aniline hydrochloride. IARC Monogr. Eval. Carcinog. Risk Chem. Hum. 1982, 27:39-61.
45. Ishidate M., Sofuni T., Yoshikawa K. Chromosomal aberration tests in vitro as a primary screening tool for environmental mutagens and/or carcinogens. GANN Monogr. Cancer Res 1981, 27:95-108.
46. Ito N., Hasegawa R., Sano M., Tamano S., Esumi H., Takayama S., Sugimura T. A new colon and mammary carcinogen in cooked food, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). Carcinogenesis 1991, 12:1503-1506.
47. Jägerstad M., Skog K., Grivas S., Olsson K. Formation of heterocyclic amines using model systems. Mutat. Res 1991, 259:219-233.
48. Kada T., Kato M., Aikawa K., Kiriyama S. Adsorption of pyrolysate mutagens by vegetable fibers. Mutat. Res 1984, 141:149-152.
49. Kaderlik K.R., Mulder G.J., Shaddock J.G., Casciano D.A., Teitel C.H., Kadlubar F.F. Effect of glutathione depletion and inhibition of glucuronidation and sulfation on 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) metabolism, PhIP-DNA adduct formation and unscheduled DNA synthesis in primary rat hepatocytes. Carcinogenesis 1994, 15:1711-1716.
50. Kadlubar F.F., Kaderlik K.R., Mulder G.J., Lin D., Butler M.S., Teitel C.H., Minchin R.F., Ilett K.F., Friesen M.D., Bartsch H., Nagao M., Esumi H., Sugimura T., Lang N.P. Metabolic activation and DNA adduct detection of PhIP in dogs, rats, and humans in relation to urinary bladder and colon carcinogenesis. Princess Takamatsu Symposium 1995, 23:207-213.
51. Kakiuchi H., Ushijima T., Ochiai M., Imai K., Ito N., Yachi A., Sugimura T., Nagao M. Rare frequency of activation of the Ki-ras gene in rat colon tumors induced by heterocyclic amines: possible alternative mechanisms of human colon carcinogenesis. Mol. Carcinog 1993, 8:44-48.
52. Kakiuchi H., Watanabe M., Ushijima T., Toyota M., Imai K., Weisburger J.H., Sugimura T., Nagao M. Specific 5'-GGGA-3'-> 5'-GGA-3' mutation of the Apc gene in rat colon tumors induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Proc. Natl. Acad. Sci. USA 1995, 92:910-914.
53. Kataoka H., Nishioka S., Kobayashi M., Hanaoka T., Tsugane S. Analysis of mutagenic heterocyclic amines in cooked food samples by gas chromatography with nitrogen-phosphorus detector. Bull. Environ. Contam. Toxicol 2002, 69:682-689.
54. Kato T., Ohgaki H., Hasegawa H., Sato S., Takayama S., Sugimura T. Carcinogenicity in rats of a mutagenic compound, 2-amino-3,8-dimethyl-imidazo[4,5-f]quinoxaline. Carcinogenesis 1988, 9:71-73.
55. Kato T., Migita H., Ohgaki H., Sato S., Takayama S., Sugimura T. Induction of tumors in the Zymbal gland, oral cavity, colon, skin and mammary gland of F344 rats by a mutagenic compound, 2-amino-3,4-dimethylimidazo[4,5-f]quinoline. Carcinogenesis 1989, 10:601-603.
56. Kawamori T., Totsuka Y., Uchiya N., Kitamura T., Shibata H., Sugimura T., Wakabayashi K. Carcinogenicity of aminophenylnorharman, a possible novel endogenous mutagen, formed from norharman and aniline, in F344 rats. Carcinogenesis 2004, 25:1967-1972.
57. Kitazawa T., Kominami R., Tanaka R., Wakabayashi K., Nagao M. 2-Hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine induction of recombinational mutations in mammalian cell lines as detected by DNA fingerprinting. Mol Carcinog 1994, 9:67-70.
58. Knasmûller S., Steinkellner H., Hirschl A.M., Rabot S., Nobis E.C., Kassie F. Impact of bacteria in daily products and the intestinal microflora on the genotoxic and carcinogenic effects of heterocyclic aromatic amines. Mutat. Res 2001, 480-481:129-138.
59. Kudo M., Ogura T., Esumi H., Sugimura T. Mutational activation of c-Ha-ras gene in squamous cell carcinomas of rat Zymbal gland induced by carcinogenic heterocyclic amines. Mol. Carcinog 1991, 4:36-42.
60. Lang N.P., Chu D.Z., Hunter C.F., Kendall D.C., Flammang T.J., Kadlubar F.F. Role of aromatic amine acetyltransferase in human colorectal cancer. Arch. Surg 1986, 121:1259-1261.
61. Lang N.P., Butler M.A., Massengill J., Lawson M., Stotts R.C., Hauer-Jensen M., Kadlubar F.F. Rapid metabolic phenotypes for acetyltransferase and cytochrome P4501A2 and putative exposure to foodborne heterocyclic amines increase the risk for colorectal cancer or polyps. Cancer Epidemiol. Biomarkers Prev 1994, 3:675-682.
62. Lauber S.N., Ali S., Gooderham N.J. The cooked food derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b] pyridine is a potent oestrogen: a mechanistic basis for its tissue-specific carcinogenicity. Carcinogenesis 2004, 25:2509-2517.
63. Le Marchand L., Hankin J.H., Wilkens L.R., Pierce L.M., Franke A., Kolonel L.N., Seifried A., Custer L.J., Chang W., Lum-Jones A., Donlon T. Combined effects of well-done red meat, smoking, and rapid N-acetyltransferase 2 and CYP1A2 phenotypes in increasing colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 2001, 10:1259-1266.
64. Leong-Morgenthaler P.M., Holzhauser D. Analysis of mutations induced by 2-amino-1-mehtyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in human lympho-blastoid cells. Carcinogenesis 1995, 16:713-718.
65. Lightfoot T.J., Coxhead J.M., Cupid B.C., Nicholson S., Garner R.C. Analysis of DNA adducts by accelerator mass spectrometry in human breast tissue after administration of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and benzo[a]pyrene. Mutat Res 2000, 472:119-127.
66. Luceri F., Giuseppe P., Moneti G., Dolara P. Primary aromatic amines from side-stream cigarette smoke are common contaminants of indoor air. Toxicol. Ind. Health 1993, 9:405-413.
67. Magagnotti C., Orsi F., Bagnati R., Celli N., Rotilio D., Fanelli R., Airoldi L. Effect of diet on serum albumin and hemoglobin adducts of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in humans. Int. J. Cancer 2000, 88:1-6.
68. Magagnotti C., Pastorelli R., Pozzi S., Andreoni B., Fanelli R., Airoldi L. Genetic polymorphisms and modulation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-DNA adducts in human lymphocytes. Int. J. Cancer 2003, 107:878-884.
69. Makino H., Ishizaka Y., Tsujimoto A., Nakamura T., Onda M., Sugimura T., Nagao M. Rat p53 gene mutations in primary Zymbal gland tumors induced by 2-amino-3-methylimidazo[4,5-f]quinoline, a food mutagen. Proc. Natl. Acad. Sci. USA 1992, 89:4850-4854.
70. Makino H., Ochiai M., Caignard A., Ishizaka Y., Onda M., Sugimura T., Nagao M. Detection of a Ha-ras point mutation by polymerase chain reaction-single strand conformation polymorphism analysis in 2-amino-3,4-dimethylimidazo[4,5-f]quinoline-induced mouse forestomach tumors. Cancer Lett 1992, 62:115-121.
71. Makino H., Ushijima T., Kakiuchi H., Onda M., Ito N., Sugimura T., Nagao M. Absence of p53 mutations in rat colon tumors induced by 2-amino-6-methyl-dipyrido[1,2-a:3',2'-d]imidazole, 2-amino-3-methylimidazo[4,5-f]quinoline, or 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Jpn. J. Cancer Res 1994, 85:510-514.
72. Masumura K., Horiguchi M., Nishikawa A., Umemura T., Kanki K., Kanke Y., Nohmi T. Low dose genotoxicity of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MelQx) in gpt delta transgenic mice. Mutat. Res 2003, 541:91-102.
73. Masumura K., Totsuka Y., Wakabayashi K., Nohmi T. Potent genotoxicity of aminophenylnorharman, formed from non-mutagenic norharman and aniline, in the liver of gpt delta transgenic mouse. Carcinogenesis 2003, 24:1985-1993.
74. Matsukura N., Kawachi T., Morino K., Ohgaki H., Sugimura T., Takayama S. Carcinogenicity in mice of mutagenic compounds from tryptophan pyrolyzate. Science 17 Jul 1981, 213(4505):346-347.
75. Minchin R.F., Reeves P.T., Teitel C.H., Mcmanus M.E., Mojarrabi B., Illett K.F., Kadlubar F.F. N- and O-acetylation of aromatic and HCA carcinogens by human monomorphic and polymorphic acetyltransferases expressed in COS-1 cells. Biochem. Biophys. Res. Commun 1992, 185:839-844.
76. Muckel E., Frandsen H., Glatt H.R. Heterologous expression of human N-acetyltransferases 1 and 2 and sulfotransferase 1A1 in Salmonella typhimurium for mutagenicity testing of heterocyclic amines. Food. Chem. Toxicol 2002, 40:1063-1068.
77. Murayama N., Soyama A., Saito Y., Nakajima Y., Komamura K., Ueno K., Kamakura S., Kitakaze M., Kimura H., Goto Y., Saitoh O., Katoh M., Ohnuma T., Kawai M., Sugai K., Ohtsuki T., Suzuki C., Minami N., Ozawa S., Sawada J. Six novel nonsynonymous CYP1A2 gene polymorphisms: catalytic activities of the naturally occurring variant enzymes. J. Pharmacol. Exp. Ther 2004, 308:300-306.
78. Nagao M. A new approach to risk estimation of food-borne carcinogens - heterocyclic amines - based on molecular information. Mutat, Res 1999, 431:3-12.
79. Food-borne Carcinogens Heterocyclic Amines 2000, John Wiley & Sons, Ltd., Chichester, New York, Weinheim, Brisbane, Singapore, Toronto. M. Nagao, T. Sugimura (Eds.).
80. Nagao M., Yahagi T., Honda M., Seino Y., Matsushima T., Sugimura T. Demonstration of mutagenicity of aniline and o-toluidine by norharman. Proc. Japan Acad 1977, 53B:34-37.
81. Nagao M., Ushijima T., Toyota M., Inoue R., Sugimura T. Genetic changes induced by heterocyclic amines. Mutat. Res 1997, 376:161-167.
82. Nakayasu M., Nakasato F., Sakamoto H., Terada M., Sugimura T. Mutagenic activity of heterocyclic amines in Chinese hamster lung cells with diphtheria toxin resistance as a marker. Mutat. Res 1983, 118:91-102.
83. Nishigaki R., Totsuka Y., Takamura-Enya T., Sugimura T., Wakabayashi K. Identification of cytochrome P-450s involved in the formation of APNH from norharman with aniline. Mutat. Res 2004, 562:19-25.
84. Norat T., Bingham S., Ferrari P., Slimani N., Jenab M., Mazuir M., Overvad K., Olsen A., Tjonneland A., Clavel F., Boutron-Ruault M.C., Kesse E., Boeing H., Bergmann M.M., Nieters A., Linseisen J., Trichopoulou A., Trichopoulos D., Tountas Y., Berrino F., Palli D., Panico S., Tumino R., Vineis P., Bueno-De-Mesquita H.B., Peeters P.H., Engeset D., Lund E., Skeie G., Ardanaz E., Gonzalez C., Navarro C., Quiros J.R., Sanchez M.J., Berglund G., Mattisson I., Hallmans G., Palmqvist R., Day N.E., Khaw K.T., Key T.J., San Joaquin M., Hemon B., Saracci R., Kaaks R., Riboli E. Meat, fish, and colorectal cancer risk: the European Prospective Investigation into cancer and nutrition. J. Natl. Cancer Inst 2005, 97:906-916.
85. Nowell S.A., Massengill J.S., Williams S., Radominska-Pandya A., Tephly T.R., Cheng Z., Strassburg C.P., Tukey R.H., Macleod S.L., Lang N.P., Kadlubar F.F. Glucuronidation of 2-hydroxyamino-1-methyl-6-phenylimidazo[4, 5-b]pyridine by human microsomal UDP-glucuronosyltransferases: identification of specific UGT1A family isoforms involved. Carcinogenesis 1999, 20:1107-1114.
86. Nozawa H., Tazumi K., Sato K., Yoshida A., Tanaka J., Arimoto-Kobayashi S., Kondo K. Inhibitory effects of beer on heterocyclic amine-induced mutagenesis and PhIP-induced aberrant crypt foci in rat colon. Mutat. Res 2004, 559:177-187.
87. Nozawa H., Nakao W., Takata J., Arimoto-Kobayashi S., Kondo K. Inhibition of PhIP-induced mammary carcinogenesis in female rats of freeze-dried beer. Cancer Lett 2006, article in press.
88. Ohe T., Takata T., Maeda Y., Totsuka Y., Hada N., Matsuoka A., Tanaka N., Wakabayashi K. Induction of sister chromatid exchange and chromosome aberrations in cultured mammalian cells treated with aminophenylnorharman formed by norharman with aniline. Mutat. Res 2002, 515:181-188.
89. Ohgaki H., Kusama K., Matsukura N., Morino K., Hasegawa H., Sato S., Takayama S., Sugimura T. Carcinogenicity in mice of a mutagenic compound, 2-amino-3-methylimidazo[4,5-f]quinoline, from broiled sardine, cooked beef and beef extract. Carcinogenesis 1984, 5:921-924.
90. Ohgaki H., Matsukura N., Morino K., Kawachi T., Sugimura T., Takayama S. Carcinogenicity in mice of mutagenic compounds from glutamic acid and soybean globulin pyrolysates. Carcinogenesis 1984, 5:815-819.
91. Ohgaki H., Hasegawa H., Suenaga M., Kato T., Sato S., Takayama S., Sugimura T. Induction of hepatocellular carcinoma and highly metastatic squamous cell carcinomas in the forestomach of mice by feeding 2-amino-3,4-dimethyl-imidazo[4,5-f]quinoline. Carcinogenesis 1986, 7:1889-1893.
92. Ohgaki H., Hasegawa H., Suenaga M., Sato S., Takayama S., Sugimura T. Carcinogenicity in mice of a mutagenic compound, 2-amino-3,8-dimethyl-imidazo[4,5-f]quinoxaline (MeIQx) from cooked foods. Carcinogenesis 1987, 8:665-668.
93. Ohgaki H., Takayama S., Sugimura T. Carcinogenicities of heterocyclic amines in cooked food. Mutat Res 1991, 259:399-410.
94. Okochi E., Watanabe N., Shimada Y., Takahashi S., Wakazono K., Shirai T., Sugimura T., Nagao M., Ushijima T. Preferential induction of guanine deletion at 5'-GGGA-3' in rat mammary glands by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Carcinogenesis 1999, 20:1933-1938.
95. Okochi E., Watanabe N., Sugimura T., Ushijima T. Single nucleotide instability: a wide involvement in human and rat mammary carcinogenesis?. Mutat. Res 2002, 506-507:101-111.
96. Okonogi H., Ushijima T., Zhang X.B., Heddle J.A., Suzuki T., Sofuni T., Felton J.S., Ticker J.D., Sugimura T. Agreement of mutational characteristics of heterocyclic amines in lacI of the Big Bluer mouse with those in tumor-related genes in rodents. Carcinogenesis 1997, 18:745-748.
97. Ozawa S., Tang Y.M., Yamazoe Y., Kato R., Lang N.P., Kadlubar F.F. Genetic polymorphisms in human liver phenol sulfotransferases involved in the bioactivation of N-hydroxy derivatives of carcinogenic arylamines and heterocyclic amines. Chem. Biol. Interact 1998, 109:237-248.
98. Parkin D.M. Global cancer statistics in the year 2000. Lancet Oncol 2001, 2:533-543.
99. Probst-Hensch N.M., Sinha R., Longnecker M.P., Witte J.S., Ingles S.A., Frankl H.D., Lee E.R., Haile R.W. Meat preparation and colorectal adenomas in a large sigmoidoscopy-based case-control study in California (United States). Cancer Causes Control 1997, 8:175-183.
100. Qiu C., Shan L., Yu M., Snyderwine E.G. Steroid hormone receptor expression and proliferation in rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Carcinogenesis 2005, 26:763-769.
101. Reddy B.S., Rivenson A. Inhibitory effect of Bifidobacterium longum on colon, mammary, and liver carcinogenesis induced by 2-amino-3-methyl-imidazo[4,5-f]quinoline, a food mutagen. Cancer Res 1993, 53:3914-3918.
102. Reistad R., Rossland O.J., Latva-Kala K.J., Rasmussen T., Vikse R., Becher G., Alexander J. Heterocyclic aromatic amines in human urine following a fried meat meal. Food Chem. Toxicol 1997, 35:945-955.
103. Reistad R., Nyholm S.H., Haug L.S., Becher G., Alexander J. 2-Amino-1-methyl-6-phenylimidazo 4,5-b pyridine (PhIP) in human hair as a biomarker for dietary exposure. Biomarkers 1999, 4:263-271.
104. Renskers K.J., Feor K.D., Roth J.A. Sulfation of dopamine and other biogenic amines by human brain phenol sulfotransferase. J. Neurochem 1980, 34:1362-1368.
105. Riffelmann M., Muller G., Schmieding W., Popp W., Norpoth K. Biomonitoring of urinary aromatic amines and arylamine hemoglobin adducts in exposed workers and nonexposed control persons. Int. Arch. Occup. Environ. Health 1995, 68:36-43.
106. Roberts-Thomson I.C., Ryan P., Khoo K.K., Hart W.J., Mcmichael A.J., Butler R.N. Diet, acetylator phenotype, and risk of colorectal neoplasia. Lancet 1996, 347:1372-1374.
107. Sawada S., Yamanaka T., Yamatsu K., Furihata C., Matsushima T. Chromosome aberrations, micronuclei and sister-chromatid exchanges (SCEs) in rat liver induced in vivo by hepatocarcinogens iucluding heterocyclic amines. Mutat. Res 1991, 251:59-69.
108. Sawada S., Daimon H., Asakura S., Kawaguchi T., Yamatsu K., Furihata C., Matsushima T. Cumulative effects of chromosome aberrations and sister chromatid exchanges in rat liver induced in vivo by heterocyclic amines. Carcinogenesis 1994, 15:285-290.
109. Schweikl H., Taylor J.A., Kitareewan S., Linko P., Nagorney D., Goldstein J.A. Expression of CYP1A1 and CYP1A2 genes in human liver. Pharmacogenetics 1993, 3:239-249.
110. Shimada T., Guengerich F.P. Activation of amino-α-carboline, 2-amino-1-methyl-6-phenyimidazo[4,5-b]pyridine, and a copper phthalocyanine cellulose extract of cigarette smoke condensate by cytochrome P-450 enzymes in rat and human liver microsomes. Cancer Res 1991, 51:5284-5291.
111. Shirai T., Sano M., Tamano S., Takahashi S., Hirose M., Futakuchi M., Hasegawa R., Imaida K., Matsumoto K., Wakabayashi K., Sugimura T., Ito N. The prostate: a target for carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) derived from cooked foods. Cancer Res 1997, 15:195-198.
112. Sinha R., Rothman N., Brown E.D., Mark S.D., Hoover R.N., Caporaso N.E., Levander O.A., Knize M.G., Lang N.P., Kadlubar F.F. Pan-fried meat containing high levels of heterocyclic aromatic amines but low levels of polycyclic aromatic hydrocarbons induces cytochrome P4501A2 activity in humans. Cancer Res 1994, 6:154-159.
113. Sinha R., Kulldorff M., Curtin J., Brown C.C., Alavanja M.C., Swanson C.A. Fried, well-done red meat and risk of lung cancer in women (United States). Cancer Causes Control 1998, 9:621-630.
114. Sinha R., Chow W.H., Kulldorff M., Denobile J., Butler J., Garcia-Closas M., Weil R., Hoover R.N., Rothman N. Well-done, grilled red meat increases the risk of colorectal adenomas. Cancer Res 1999, 59:4320-4324.
115. Sinha R., Gustafson D.R., Kulldorff M., Wen W.Q., Cerhan J.R., Zheng W. 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, a carcinogen in high-temperature-cooked meat, and breast cancer risk. J. Natl. Cancer Inst 2000, 92:1352-1354.
116. Sinha R., Kulldorff M., Swanson C.A., Curtin J., Brownson R.C., Alavanja M.C. Dietary heterocyclic amines and the risk of lung cancer among Missouri women. Cancer Res 2000, 60:3753-3756.
117. Skipper P.L., Tannenbaum S.R. Molecular dosimetry of aromatic amines in human populations. Environmental Health Perspectives 1994, 102(Supp 6):17-21.
118. Skog K., Knize M.G., Felton J.S., Jägerstad M. Formation of new heterocyclic amine mutagens by heating creatinine, alanine, threonine and glucose. Mutat. Res 1992, 268:191-197.
119. Sugimura T. Studies on environmental chemical carcinogenesis in Japan. Science 1986, 233:312-318.
120. Sugimura T. Multistep carcinogenesis: A 1992 perspective. Science 1992, 258:603-607.
121. Sugimura T. A new concept of co-mutagenicity from a phenomenon forgotten for the past two decades: Is it more important than previously expected?. Environ. Health Perspect 1998, 106:A522-A523.
122. Sugimura T., Kawachi T., Nagao M., Yahagi T., Seino Y., Okamoto T., Shudo K., Kosuge T., Tsuji K., Wakabayashi K., Iitaka Y., Itai A. Mutagenic principle(s) in tryptophan and phenylalanine pyrolysis products. Proc. Jpn. Acad 1977, 53:58-61.
123. Sugimura T., Nagao M., Wakabayashi K. Metabolic aspects of the comutagenic action of norharman. Biological Reactive Intermediates-II, Chemical Mechanisms and Biological Effects Part B 1982, 1011-1025. Plenum Press, NY and London. R. Snyder, D.J. Jollow, D.V. Parke, C.G. Gibson, J.J. Kocsis, C.M. Witmer (Eds.).
124. Sugimura T., Nagao M., Wakabayashi K. How we should deal with unavoidable exposure of man to environmental mutagens: cooked food mutagen discovery, facts and lessons for cancer prevention. Mutat Res 2002, 447:15-25.
125. Sugimura T., Wakabayashi K., Nakagama H., Nagao M. Heterocyclic amines: Mutagens/carcinogens produced during cooking of meat and fish. Cancer Sci 2004, 95:290-299.
126. Takahashi M., Minamoto T., Sugimura T., Esumi H. High frequency and low specificity of ras gene mutations in rat Zymbal's gland tumors induced by 2-amino-3-methylimidazo[4,5-f]quinoline. Carcinogenesis 1993, 14:1355-1357.
127. Takahashi M., Toyoda K., Aze Y., Furuta K., Mitsumori K., Hayashi Y. The rat urinary bladder as a new target of heterocyclic amine carcinogenicity: tumor induction by 3-amino-1-methyl-5H-pyrido[4,3-b]indole acetate. Jpn J. Cancer Res 1993, 84:852-858.
128. Takahashi M., Totsuka Y., Masuda M., Fukuda K., Oguri A., Yazawa K., Sugimura T., Wakabayashi K. Reduction in formation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced aberrant crypt foci in the rat colon by docosahexaenoic acid (DHA). Carcinogenesis 1997, 18:1937-1941.
129. Takayama S., Masuda M., Mogami M., Ohgaki H., Sato S., Sugimura T. Induction of cancers in the intestine, liver and various other organs of rats by feeding mutagens from glutamic acid pyrolysate. Gann 1984, 75:207-213.
130. Takayama S., Nakatsuru Y., Masuda M., Ohgaki H., Sato S., Sugimura T. Demonstration of carcinogenicity in F344 rats of 2-amino-3-methyl-imidazo[4,5-f]quinoline from broiled sardine, fried beef and beef extract. Gann 1984, 75:467-470.
131. Takayama S., Nakatsuru Y., Ohgaki H., Sato S., Sugimura T. Carcinogenicity in rats of a mutagenic compound, 3-amino-1,4-dimethyl-5H-pyrido[4,3-b]indole, from tryptophan pyrolysate. Jpn J. Cancer Res 1985, 76:815-817.
132. Tamano S., Hasegawa R., Hagiwara A., Nagao M., Sugimura T., Ito N. Carcinogenicity of a mutagenic compound from food, 2-amino-3-methyl-9H-pyrido[2,3-b]indole (MeA alpha C), in male F344 rats. Carcinogenesis 1994, 15:2009-2015.
133. Tanaka T., Suzuki R., Kohno H., Sugie S., Takahashi M., Wakabayashi K. Colonic adenocarcinomas rapidly induced by the combined treatment with 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and dextran sodium sulfate in male ICR mice possess β-catenin gene mutations and increased immunoreactivity for β-catenin, cyclooxygenase-2 and inducible nitric oxide synthase. Carcinogenesis 2005, 26:229-238.
134. Terada M., Nagao M., Nakayasu M., Sakamoto H., Nakasato F., Sugimura T. Mutagenic activities of heterocyclic amines in Chinese hamster lung cells in culture. Environ. Health Perspect 1986, 67:117-119.
135. Thompson L.H., Carrano A.V., Salazar E., Felton J.S., Hatch F.T. Comparative genotoxic effects of the cooked-food-related mutagens Trp-P-2 and IQ in bacteria and cultured mammarian cells. Mutat. Res 1983, 117:243-257.
136. Tohda H., Oikawa A., Kawachi T., Sugimura T. Induction of sister-chromatid exchanges by mutagens from amino acid and protein pyrolysates. Mutat. Res 1980, 77:65-69.
137. 2-(deoxyguanosin-8-yl)-2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (dG-C8-MeIQx) in human tissues. Carcinogenesis 1996, 17:1029-1034.
138. Totsuka Y., Hada N., Matsumoto K., Kawahara N., Murakami Y., Yokoyama Y., Sugimura T., Wakabayashi K. Structural determination of a mutagenic aminophenylnorharman produced by the co-mutagen norharman with aniline. Carcinogenesis 1998, 19:1995-2000.
139. Totsuka Y., Ushiyama H., Ishihara J., Sinha R., Goto S., Sugimura T., Wakabayashi K. Quantification of the co-mutagenic β-carbolines, norharman and harman, in cigarette smoke condensates and cooked foods. Cancer Lett 1999, 143:139-143.
140. Totsuka Y., Takamura-Enya T., Nishigaki R., Sugimura T., Wakabayashi K. Mutagens formed from β-carboline with aromatic amines. J. Chromatogr. B 2004, 802:135-141.
141. Tsuda M., Negishi C., Makino R., Sato S., Yamaizumi Z., Hirayama T., Sugimura T. Use of nitrite and hypochlorite treatments in determination of the contributions of IQ-type and non-IQ-type heterocyclic amines to the mutagenicities in crude pyrolyzed materials. Mutat. Res 1985, 147:335-341.
142. Tsuda H., Sekine K., Uehara N., Takasuka N., Moore M.A., Konno Y., Nakashita K., Degawa M. Heterocyclic amine mixture carcinogenesis and its enhancement by caffeine in F344 rats. Cancer Lett 1999, 143:229-234.
143. Tsuda H., Sekine K., Fujita K., Iigo M. Cancer prevention by bovine lactoferrin and underlying mechanisms - a review of experimental and clinical studies. Biochem. Cell. Biol 2002, 80:131-136.
144. Turesky R.J. Interspecies metabolism of heterocyclic aromatic amines and the uncertainties in extrapolation of animal toxicity data for human risk assessment. Mol. Nutr. Food Res 2005, 49:101-117.
145. Turesky R.J., Vouros P. Formation and analysis of heterocyclic aromatic amine-DNA adducts in vitro and. in vivo. J. Chromatogr. B 2004, 802:155-166.
146. Turesky R.J., Rossi S.C., Welti D.H., Lay J.O., Kadlubar F.F. Characterization of DNA adducts formed in vitro by reaction of N-hydroxy-2-amino-3-methylimidazo[4,5-f]quinoline and N-hydroxy-2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline at the C-8 and N2 atoms of guanine. Chem Res Toxicol 1992, 5:479-490.
147. Turteltaub K.W., Mauthe R.J., Dingley K.H., Vogel J.S., Frantz C.E., Garner R.C., Shen N. MeIQx-DNA adduct formation in rodent and human tissues at low doses. Mutat Res 1997, 12:243-252.
148. Turteltaub K.W., Dingley K.H., Curtis K.D., Malfatti M.A., Turesky R.J., Garner R.C., Felton J.S., Lang N.P. Macromolecular adduct formation and metabolism of heterocyclic amines in humans and rodents at low doses. Cancer Letters 1999, 143:149-155.
149. Ubagai T., Ochiai M., Kawamori T., Imai H., Sugimura T., Nagao M., Nakagama H. Efficient induction of rat large intestinal tumors with a new spectrum of mutations by intermittent administration of 2-amino-1-methyl-6-phenyl-imidazo[4,5-b]pyridine in combination with a high fat diet. Carcinogenesis 2002, 23:197-200.
150. Umemoto A., Monden Y., Grivas S., Yamashita K., Sugimura T. Determination of human exposure to the dietary carcinogen 3-amino-1, 4-dimethyl-5H-pyrido[4,3-b]indole (Trp-P-1) from hemoglobin adducts: the relationship to DNA adducts. Carcinogenesis 1992, 13:1025-1030.
151. Ushijima T., Kakiuchi H., Makino H., Hasegawa R., Ishizuka Y., Hirai H., Yazaki Y., Ito N., Sugimura T., Nagao M. Infrequent mutation of Ha-ras and p53 in rat mammary carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Mol. Carcinog 1994, 10:38-44.
152. Ushijima T., Makino H., Kakiuchi H., Inoue R., Sugimura T., Nagao M. Genetic alterations in HCA-induced tumors. Heterocyclic amines in cooked foods: Possible human carcinogens 1995, 281-291. Princeton Scientific Publishing, Princeton, NJ, 1995. R.H. Adamson, J.-A. Gustafsson, N. Ito, M. Nagao, T. Sugimura, K. Wakabayashi, Y. Yamazoe (Eds.).
153. Ushijima T., Makino H., Okonogi H., Hosoya Y., Sugimura T., Nagao M. Mutation, loss of heterozygosity, and recombination of the p53 gene in mouse forestomach tumors induced by 2-amino-3,4-dimethylimidazo[4,5-f]quinoline. Mol. Carcinog 1995, 12:23-30.
154. Ushiyama H., Wakabayashi K., Hirose M., Itoh H., Sugimura T., Nagao M. Presence of carcinogenic heterocyclic amines in urine of healthy volunteers eating normal diet, but not of inpatients receiving parenteral alimentation. Carcinogenesis 1991, 12:1417-1422.
155. Ushiyama H., Oguri A., Totsuka Y., Itoh H., Sugimura T., Wakabayashi K. Norharman and harman in human urine. Proc. Jpn. Acad 1995, 71B:57-60.
156. Wakabayashi K., Nagao M., Esumi H., Sugimura T. Food-derived mutagens and carcinogens. Cancer Res 1992, 52:2092-2098.
157. Wakabayashi K., Sugimura T. Heterocyclic amines formed in the diet: Carcinogenicity and its modulation by dietary factors. J. Nutr. Biochem 1998, 9:604-612.
158. Ward M.H., Sinha R., Heineman E.F., Rothman N., Markin R., Weisenburger D.D., Correa P., Zahm S.H. Risk of adenocarcinoma of the stomach and esophagus with meat cooking method and doneness preference. Int. J. Cancer 1997, 71:14-19.
159. Watanabe N., Okochi E., Mochizuki M., Sugimura T., Ushijima T. The presence of single nucleotide instability in human breast cancer cell lines. Cancer Res 2001, 61:7739-7742.
160. Welfare M.R., Cooper J., Bassendine M.F., Daly A.K. Relationship between acetylator status, smoking, and diet and colorectal cancer risk in the north-east of England. Carcinogenesis 1997, 18:1351-1354.
161. Wu R.W., Wu E.M., Thompson L.H., Felton J.S. Identification of aprt gene mutations induced in repair-deficient and P450-expressing CHO cells by the food-related mutagen/carcinogen, PhIP. Carcinogenesis 1995, 16:1207-1213.
162. Xu M., Baily A.C., Hernaez J.F., Taoka C.R., Schut H.A.J., Dashwood R.H. Protection by green tea, black tea, and indole-3-carbinol against 2-amino-3-methylimidazo[4,5-f]quinoline-induced DNA adducts and colonic aberrant crypt in the F344 rat. Carcinogenesis 1996, 17:1429-1434.
163. Xu M., Schut H.A.J., Bjeldanes L.F.B., Williams D.E., Baily G.S., Dashwood R.H. Inhibition of 2-amino-3-methylimidazo[4,5-f]quinoline-DNA adducts by indole-3-carbinol: Dose-response studies in the rat colon. Carcinogenesis 1997, 18:2149-2153.
164. Yadollahi-Farsani M., Gooderham N.J., Davies D.S., Boobis A.R. Mutation spectra of the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (phIP) at the Chinese hamster hprt locus. Carcinogenesis 1996, 17:617-624.
165. Yamaguchi K., Zenda H., Shudo K., Kosuge T., Okamoto T., Sugimura T. Presence of 2-aminodipyrido[1,2-a:3',2'-d]imidazole in casein pyrolysate. Gann 1979, 70:849-850.
166. Yamamoto T., Tsuji K., Kosuge T., Okamoto T., Shudo K., Takeda K., Iitaka Y., Yamaguchi K., Seino Y., Yahagi T., Nagao M., Sugimura T. Isolation and structure determination of mutagenic substances in L-glutamic acid pyrolysate. Proc. Jpn. Acad 1978, 54B:248-250.
167. Yamazoe Y., Shimada M., Kamataki T., Kato R. Microsomal activation of 2-amino-3-methylimidazo[4,5-f]quinoline, a pyrolysate of sardine and beef extracts, to a mutagenic intermediate. Cancer Res 1983, 43:5768-5774.
168. Yoshida D., Matsumoto T. Isolation of 2-amino-9H-pyrido[2,3-b]indole and 2-amino-3-methyl-9H-pyrido[2,3-b]indole as mutagens from pyrolysis product of tryptophan. Agric. Biol. Chem 1979, 43:1155-1156.
169. Yoshida D., Matsumoto T., Yoshimura R., Matsuzaki T. Mutagenicity of amino-a-carbolines in pyrolysis products of soybean globulin. Biochem. Biophys. Res. Commun 1978, 83:915-920.
170. Zheng W., Gustafson D.R., Sinha R., Cerhan J.R., Moore D., Hong C.P., Anderson K.E., Kushi L.H., Sellers T.A., Folsom A.R. Well-done meat intake and the risk of breast cancer. J. Natl. Cancer Inst 1998, 90:1724-1729.
171. Zhou H., Josephy P.D., Kim D., Guengerich F.P. Functional characterization of four allelic variants of human cytochrome P450 1A2. Arch. Biochem. Biophys 2004, 422:23-30.
172. Zsivkovits M., Fekadu K., Sontag G., Nabinger U., Huber W.W., Kundi M., Chakraborty A., Foissy H., Knasmuller S. Prevention of heterocyclic amine-induced DNA damage in colon and liver of rats by different lactobacillus strains. Carcinogenesis 2003, 24:1913-1918.